Valneva’s IXCHIQ Chikungunya Vaccine Approved for Ages 12+
The European Medicines Agency and regulatory bodies globally recognize Valneva Austria GmbH’s IXCHIQ as a critical live-attenuated single-dose vaccine providing active immunization against the chikungunya virus. Authorized for individuals aged ... Read More